{"id":"W2504204972","doi":"10.1182/blood.v124.21.292.292","title":"Brentuximab Vedotin Combined with ABVD or AVD for Patients with Newly Diagnosed Advanced Stage Hodgkin Lymphoma: Long Term Outcomes","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"ABVD; Brentuximab vedotin; Dacarbazine; Medicine; Vinblastine; Regimen; Internal medicine; Bleomycin; Surgery; Oncology; Gastroenterology; Lymphoma; Vincristine; Chemotherapy; CD30","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009613049,0.000273422,0.0007970253,0.0002337952,0.0003832028,0.000548341,0.0002367197,0.0004304252,0.000733932],"category_scores_gemma":[0.0006808028,0.0001344231,0.0006829538,0.0002649071,0.0003418178,0.0005398412,0.0004531423,0.0009838416,0.0002147696],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005502037,"about_ca_system_score_gemma":0.0006420886,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000788775,"about_ca_topic_score_gemma":0.001508524,"domain_scores_codex":[0.9997321,0.00008135734,0.00002578212,0.00004740719,0.00004345274,0.00006992158],"domain_scores_gemma":[0.9990925,0.00009881703,0.0002824832,0.00004747256,0.00005114586,0.0004276277],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.2316437,0.03304755,0.3198322,0.001302318,0.002055542,0.002076489,0.0006925334,0.00233712,0.02360476,0.0002443827,0.003517419,0.3796459],"study_design_scores_gemma":[0.03409441,0.5240316,0.4229178,0.0002393912,0.002055604,0.002503081,0.000264913,0.001619618,0.003923903,0.0002903405,0.008007932,0.00005134221],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946519,0.004076219,0.000144339,0.0001252582,0.00004303539,0.0001622768,0.0001976005,0.000008926103,0.0005903925],"genre_scores_gemma":[0.9966894,0.001590628,0.0001795405,0.0003133634,0.0001141965,0.0001260777,0.0005965215,0.000002496029,0.0003877375],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0009613049,"threshold_uncertainty_score":0.005083919,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009953442662376038,"score_gpt":0.2470614320194354,"score_spread":0.2371079893570593,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}